TY  - GEN
AU  - Burris,Scott
AU  - Davis,Corey
TI  - Assessing social risks prior to commencement of a clinical trial: due diligence or ethical inflation?
SN  - 1536-0075
PY  - 2009///1214
KW  - Adult
KW  - Buprenorphine
KW  - therapeutic use
KW  - Buprenorphine, Naloxone Drug Combination
KW  - China
KW  - Confidentiality
KW  - ethics
KW  - Conflict of Interest
KW  - Counseling
KW  - Ethics Committees, Research
KW  - Ethics, Research
KW  - Female
KW  - Financing, Government
KW  - HIV Infections
KW  - etiology
KW  - Health Services Accessibility
KW  - Human Rights
KW  - Humans
KW  - Informed Consent
KW  - International Cooperation
KW  - Male
KW  - Middle Aged
KW  - Naloxone
KW  - Narcotic Antagonists
KW  - Opioid-Related Disorders
KW  - complications
KW  - Patient Selection
KW  - Randomized Controlled Trials as Topic
KW  - economics
KW  - Research Design
KW  - Research Subjects
KW  - Risk Assessment
KW  - Risk Reduction Behavior
KW  - Social Environment
KW  - Thailand
KW  - United States
KW  - Vulnerable Populations
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1080/15265160903197507
ER  -